Shalini Manchanda, MD
Sleep Medicine · Indianapolis, INNPI 1013073543
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $34,075 of the $43,194 with a category attached, or 78.9%. Every reported general payment came from a single manufacturer, Inspire Medical Systems, Inc.. Reporting peaked in 2023 at $16,849 and has fallen 99.2% since, to $141 in 2025. Among sleep medicine clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 36 payments — averaging $1199.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$43K
Across 110 payments — averaging $2580.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inspire Medical Systems, Inc.$284K
What the payments were for
- Consulting fees$34,07579%
- Speaking & faculty fees$2,0005%
- Travel & lodging$2,2625%
- Food & beverage$1,9515%
- Education$2,9067%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 36 | $43,194 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire Upper Airway Stimulation System$25,804
- Inspire$16,874
How this compares
$43,194 in reported general payments places this provider in the 95th percentile of 32 sleep medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 51 | $619 |
| Clonazepam | 38 | $315 |
| Pregabalin | 17 | $241 |
| Methylphenidate Hcl | 13 | $212 |
| Ropinirole Hcl | 14 | $200 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 14 | $46 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Indianapolis
- Adam LenetIndianapolis$5K
- Alaa ShammahIndianapolis$3K
- Joshua BarzilaiIndianapolis$2K
- Anil AchaenIndianapolis$2K
- Yuzhu TangIndianapolis$1K
- Tarek DabboussiIndianapolis$1K
- Stephanie StahlIndianapolis$667
- Rohan ThompsonIndianapolis$509
- Anita RajagopalIndianapolis$282
- Milton Marvin ChuaIndianapolis$110
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.